Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Mirtazapine 15mg orodispersible tablets |
BNF code | 0403040X0AAALAL |
Virtual Therapeutic Moiety | Mirtazapine |
Date identifier became valid | 22 Sep 2023 |
Previous product identifier | 375194009 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Mirtazapine |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 15.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tabletdispersible.oral |
Dose Form | |
Formulation | Orodispersible tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Mirtazapine 15mg orodispersible tablets (A A H Pharmaceuticals Ltd) | |
Mirtazapine 15mg orodispersible tablets (Accord-UK Ltd) | |
Mirtazapine 15mg orodispersible tablets (Alliance Healthcare (Distribution) Ltd) | |
Mirtazapine 15mg orodispersible tablets (Almus Pharmaceuticals Ltd) | |
Mirtazapine 15mg orodispersible tablets (Medihealth (Northern) Ltd) | |
Mirtazapine 15mg orodispersible tablets (Medreich Plc) | |
Mirtazapine 15mg orodispersible tablets (Milpharm Ltd) | |
Mirtazapine 15mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) | |
Mirtazapine 15mg orodispersible tablets (Sigma Pharmaceuticals Plc) | |
Virtual Medicinal Product Packs | |
Mirtazapine 15mg orodispersible tablets 30 tablet | |
Mirtazapine 15mg orodispersible tablets 6 tablet |
dm+d data retrieved from TRUD: release NHSBSA_9.4.0_20240930000001, imported on 30th September 2024 at 04:54:33.